Tags

Type your tag names separated by a space and hit enter

Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world's most vaccine-hesitant countries.
Vaccine. 2022 01 21; 40(2):178-182.V

Abstract

France is one of the most vaccine-hesitant countries in the world, including for coronavirus disease 2019 (COVID-19). After 10 months of restrictive measures and media coverage of the dangers of COVID-19, French attitudes towards a vaccine continue to deteriorate. The communication strategies of the government have not helped; in fact, they have made the situation worse. Empirical studies on the national strategy for management of the COVID-19 pandemic in France have shed light on the reasons for vaccine hesitancy. These studies have identified four pillars for the vaccination strategy: i) Communication regarding the importance of herd immunity, ii) making healthcare workers the focus of the vaccination campaign, iii) citizen mobilization and guaranteed consultations, and iv) access to free vaccines without delay. This paper discusses the evidence supporting this strategy.

Authors+Show Affiliations

SSMIP, CHU Bordeaux, Bordeaux, France; MeRISP, Centre Inserm U 1219, Bordeaux Population Health, Université de Bordeaux, France. Electronic address: Linda.cambon@u-bordeaux.fr.SSMIP, CHU Bordeaux, Bordeaux, France; MeRISP, Centre Inserm U 1219, Bordeaux Population Health, Université de Bordeaux, France.SSMIP, CHU Bordeaux, Bordeaux, France; MeRISP, Centre Inserm U 1219, Bordeaux Population Health, Université de Bordeaux, France.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

34863619

Citation

Cambon, L, et al. "Increasing Acceptance of a Vaccination Program for Coronavirus Disease 2019 in France: a Challenge for One of the World's Most Vaccine-hesitant Countries." Vaccine, vol. 40, no. 2, 2022, pp. 178-182.
Cambon L, Schwarzinger M, Alla F. Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world's most vaccine-hesitant countries. Vaccine. 2022;40(2):178-182.
Cambon, L., Schwarzinger, M., & Alla, F. (2022). Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world's most vaccine-hesitant countries. Vaccine, 40(2), 178-182. https://doi.org/10.1016/j.vaccine.2021.11.023
Cambon L, Schwarzinger M, Alla F. Increasing Acceptance of a Vaccination Program for Coronavirus Disease 2019 in France: a Challenge for One of the World's Most Vaccine-hesitant Countries. Vaccine. 2022 01 21;40(2):178-182. PubMed PMID: 34863619.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world's most vaccine-hesitant countries. AU - Cambon,L, AU - Schwarzinger,M, AU - Alla,F, Y1 - 2021/11/19/ PY - 2021/01/05/received PY - 2021/11/04/revised PY - 2021/11/08/accepted PY - 2021/12/6/pubmed PY - 2022/1/18/medline PY - 2021/12/5/entrez KW - Covid-19 KW - France KW - Models KW - Vaccine hesitancy SP - 178 EP - 182 JF - Vaccine JO - Vaccine VL - 40 IS - 2 N2 - France is one of the most vaccine-hesitant countries in the world, including for coronavirus disease 2019 (COVID-19). After 10 months of restrictive measures and media coverage of the dangers of COVID-19, French attitudes towards a vaccine continue to deteriorate. The communication strategies of the government have not helped; in fact, they have made the situation worse. Empirical studies on the national strategy for management of the COVID-19 pandemic in France have shed light on the reasons for vaccine hesitancy. These studies have identified four pillars for the vaccination strategy: i) Communication regarding the importance of herd immunity, ii) making healthcare workers the focus of the vaccination campaign, iii) citizen mobilization and guaranteed consultations, and iv) access to free vaccines without delay. This paper discusses the evidence supporting this strategy. SN - 1873-2518 UR - https://www.unboundmedicine.com/medline/citation/34863619/Increasing_acceptance_of_a_vaccination_program_for_coronavirus_disease_2019_in_France:_A_challenge_for_one_of_the_world's_most_vaccine_hesitant_countries_ L2 - https://www.clinicalkey.com/content/playBy/pii?v=S0264-410X(21)01467-5 DB - PRIME DP - Unbound Medicine ER -